RT
TWST icon

Rockland Trust’s Twist Bioscience TWST Stock Holding History

Rockland Trust’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,500
Closed -$1.32M – 304
2024
Q1 		$1.32M Hold
38,500
– – 0.07% 121
2023
Q4 		$1.42M Hold
38,500
– – 0.08% 122
2023
Q3 		$780K Buy
38,500
+8,808
+30% +$194K 0.05% 155
2023
Q2 		$607K Sell
29,692
-38,000
-56% -$569K 0.04% 185
2023
Q1 		$1.02M Hold
67,692
– – 0.06% 143
2022
Q4 		$1.61M Hold
67,692
– – 0.1% 116
2022
Q3 		$2.38M Hold
67,692
– – 0.17% 90
2022
Q2 		$2.37M Hold
67,692
– – 0.16% 91
2022
Q1 		$3.34M Hold
67,692
– – 0.21% 82
2021
Q4 		$5.24M Buy
+67,692
New +$6.95M 0.33% 74

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rockland Trust's TWST Position: Q2 2024 in Review

Rockland Trust sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 38,500 shares — an estimated $1.32M sold.

Rockland Trust first reported a position in TWST in Q4 2021 and held it in 10 quarters. The position peaked at $5.24M in Q4 2021. 263 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • Rockland Trust reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • Rockland Trust sold 38,500 Twist Bioscience shares in Q2 2024, an estimated $1.32M.
  • Rockland Trust first reported a position in Twist Bioscience in Q4 2021 and held it in 10 quarters.
  • Rockland Trust's Twist Bioscience position peaked at $5.24M in Q4 2021.
  • 263 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Rockland Trust's 13F filing for Q2 2024, filed 23 Jul 2024.